Concepedia

Nao Yoshida‐Sakai

NY

Statistics

Publications

4

Citations

61

H-Index

4

Active since

2021

Affiliations

Saga University(Current)

Nao Yoshida‐Sakai is an author at Saga University specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2021–2023

4

Publications

4

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL

Yuki Kurahashi, Tatsuro Watanabe, Yuta Yamamoto et al. · Blood Advances · 2022 · 20 citations · Full text

, , +17

Adult T‐cell leukemia‐lymphoma acquires resistance to <scp>DNA</scp> demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism

Nao Yoshida‐Sakai, Tatsuro Watanabe, Yuta Yamamoto et al. · International Journal of Cancer · 2021 · 15 citations · Full text

, , +15

Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects

Hiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe et al. · Molecular Cancer Therapeutics · 2021 · 13 citations · Full text

, , +17

Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe et al. · Cancer Research Communications · 2023 · 13 citations · Full text

, , +15

1–4 of 4